|
⚲
|
| Keyboard |
| Baker Kevin Paul
✚
|
|
|---|---|
| CIK # | 0001664512 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001664512] | |
| 4 | [0001664512] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Baker Kevin Paul | |
| Five Prime Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Five Prime Therapeutics Inc FPRX
Employee Stock Option (right to buy) · derivative
|
2018-02-26 | Grant | 20,000 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2018-02-26 | Grant | 3,500 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2018-02-05 | Tax withheld | 930 | $18.42 | 17,131 |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2018-02-01 | Tax withheld | 18,866 | $19.73 | 372,226 |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2017-09-01 | Tax withheld | 940 | $34.34 | 32,280 |
|
Five Prime Therapeutics Inc FPRX
Employee Stock Option (right to buy) · derivative
|
2017-02-07 | Grant | 25,000 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2017-02-07 | Grant | 7,031 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2017-02-07 | Grant | 5,625 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2016-08-25 | Grant | 7,500 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Common Stock
|
2016-02-01 | Grant | 75,000 | $0.00 | |
|
Five Prime Therapeutics Inc FPRX
Employee Stock Option (right to buy) · derivative
|
2016-02-01 | Grant | 75,000 | $0.00 |